BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 31162951)

  • 1. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syndecan-2 exerts antifibrotic effects by promoting caveolin-1-mediated transforming growth factor-β receptor I internalization and inhibiting transforming growth factor-β1 signaling.
    Shi Y; Gochuico BR; Yu G; Tang X; Osorio JC; Fernandez IE; Risquez CF; Patel AS; Shi Y; Wathelet MG; Goodwin AJ; Haspel JA; Ryter SW; Billings EM; Kaminski N; Morse D; Rosas IO
    Am J Respir Crit Care Med; 2013 Oct; 188(7):831-41. PubMed ID: 23924348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.
    Redente EF; Keith RC; Janssen W; Henson PM; Ortiz LA; Downey GP; Bratton DL; Riches DW
    Am J Respir Cell Mol Biol; 2014 Apr; 50(4):825-37. PubMed ID: 24325577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
    Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
    Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling.
    Boutanquoi PM; Burgy O; Beltramo G; Bellaye PS; Dondaine L; Marcion G; Pommerolle L; Vadel A; Spanjaard M; Demidov O; Mailleux A; Crestani B; Kolb M; Garrido C; Goirand F; Bonniaud P
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32184320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive Transfer of IL-33-Stimulated Macrophages into Bleomycin-Induced Mouse Models to Study Their Effect on Idiopathic Pulmonary Fibrosis In Vivo.
    Zhai X; Li J; Nie Y
    J Vis Exp; 2023 May; (195):. PubMed ID: 37212557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury.
    Aono Y; Ledford JG; Mukherjee S; Ogawa H; Nishioka Y; Sone S; Beers MF; Noble PW; Wright JR
    Am J Respir Crit Care Med; 2012 Mar; 185(5):525-36. PubMed ID: 22198976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid DNA methyltransferase3b deficiency aggravates pulmonary fibrosis by enhancing profibrotic macrophage activation.
    Qin W; Spek CA; Scicluna BP; van der Poll T; Duitman J
    Respir Res; 2022 Jun; 23(1):162. PubMed ID: 35725453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice.
    Chen Y; Wang T; Liang F; Han J; Lou Z; Yu Y; Li J; Zhan T; Gu Y; Dong L; Jiang B; Zhang W; Wu M; Lu Y
    Theranostics; 2024; 14(7):2794-2815. PubMed ID: 38773984
    [No Abstract]   [Full Text] [Related]  

  • 11. B Cells Are Not Involved in the Regulation of Adenoviral TGF-β1- or Bleomycin-Induced Lung Fibrosis in Mice.
    Moog MT; Hinze C; Bormann T; Aschenbrenner F; Knudsen L; DeLuca DS; Jonigk D; Neubert L; Welte T; Gauldie J; Kolb M; Maus UA
    J Immunol; 2022 Mar; 208(5):1259-1271. PubMed ID: 35149532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin silencing attenuates bleomycin-induced murine pulmonary fibrosis by regulating epithelial-mesenchymal transition.
    Hatipoglu OF; Uctepe E; Opoku G; Wake H; Ikemura K; Ohtsuki T; Inagaki J; Gunduz M; Gunduz E; Watanabe S; Nishinaka T; Takahashi H; Hirohata S
    Biomed Pharmacother; 2021 Jul; 139():111633. PubMed ID: 34243624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice.
    Guan S; Liu H; Zhou J; Zhang Q; Bi H
    Toxicol Lett; 2022 Jun; 363():45-54. PubMed ID: 35472619
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Fu J; Lu L; Wang H; Hou Y; Dou H
    Int J Med Sci; 2021; 18(8):1810-1823. PubMed ID: 33746598
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutting Edge: Anti-TIM-3 Treatment Exacerbates Pulmonary Inflammation and Fibrosis in Mice.
    Isshiki T; Akiba H; Nakayama M; Harada N; Okumura K; Homma S; Miyake S
    J Immunol; 2017 Dec; 199(11):3733-3737. PubMed ID: 29061768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension.
    Chen NY; D Collum S; Luo F; Weng T; Le TT; M Hernandez A; Philip K; Molina JG; Garcia-Morales LJ; Cao Y; Ko TC; Amione-Guerra J; Al-Jabbari O; Bunge RR; Youker K; Bruckner BA; Hamid R; Davies J; Sinha N; Karmouty-Quintana H
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L238-54. PubMed ID: 27317687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of necroptotic cell death in macrophages in progression of bleomycin and LPS-induced acute exacerbation of idiopathic pulmonary fibrosis.
    Koike A; Hayashi K; Fujimori K
    Eur J Pharmacol; 2024 Jun; 972():176572. PubMed ID: 38614381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice.
    Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY
    Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.